No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

SETi Releases Portable Air Purifiers with Violeds Technology for New Coronavirus Disinfection in Early June

Editor: What To Know

  • The online sales of the products will be started in both South Korea and the United States in June at first, and SETi will also continue to respond to global corporate customer's demands and inquiries.
  • However, VAC prevents harmful bacteria growing on the filter and significantly sterilizes them by irradiating the filter using Violeds' light (photon) immediately after virus capture in the air.
  • The portable air purifier VAC with Violeds embedded in the air purification system sterilizes new coronavirus and various harmful bacteria.

Sensor Electronic Technology, Inc. (“SETi”), the World’s first compound semiconductor for UV LED solutions (Violeds) and Seoul Viosys (KOSDAQ: 092190)’ subsidiary, announced that it launches portable air purifiers with Violeds technology, brand “VAC”, to reduce infection from various harmful bacteria including new coronavirus (SARS-CoV-2) in the air. The online sales of the products will be started in both South Korea and the United States in June at first, and SETi will also continue to respond to global corporate customer’s demands and inquiries.

Violeds technology has been proven to sterilize 99.9% of new coronavirus in 30 seconds according to testing results. SETi will lead product promotion to provide consumers with quicker access to sterilization solutions until this urgent situation from the global spread of new coronavirus is stabilized. The company will continue to sell the products in cooperation with potential global partners in the future. In addition, it will expand online sales to Europe and Southest Asia in June along with new portable surface sterilizers, brand named “VSM”.

The portable air purifier VAC with Violeds embedded in the air purification system sterilizes new coronavirus and various harmful bacteria. Conventional air purifiers and air conditioners collect various bacteria or viruses using only filters. Accordingly, since it couldn’t completely filter the virus out, there is a high risk of secondary air infection. However, VAC prevents harmful bacteria growing on the filter and significantly sterilizes them by irradiating the filter using Violeds’ light (photon) immediately after virus capture in the air.

HEPA filter in purification system can filter out in general fine dust and droplets more than 0.3μm but the viruses such as new coronavirus and SARS virus itself as small as 0.1μm after the droplet is dried can pass through the HEPA filter as it is.

Violeds technology provides a wide range of applications for air, water and surface sterilization, skin regeneration, insect trap and effective cultivation for horticulture.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy